# Orgovyx

NDC: 72974-120
Generic name: relugolix
Labeler / Manufacturer: Sumitomo Pharma America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20201218

FDA application: NDA214621

## Active ingredients

- RELUGOLIX: 120 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72974-120"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72974-120
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=077a92f6-9f1b-479a-87c7-c92b5db6aa9c